PLA2G6-related parkinsonism:clinical and genetic characteristics of 6 cases and literature review
10.3760/cma.j.cn113694-20230814-00049
- VernacularTitle:PLA2G6相关帕金森综合征6例临床与遗传学特点并文献复习
- Author:
Manqing XIE
1
;
Jing YUAN
;
Honglin HAO
;
Chenhui MAO
;
Yi DAI
;
Yi GUO
;
Han WANG
;
Xinhua WAN
Author Information
1. 中国医学科学院北京协和医院神经科，北京 100730
- Keywords:
Parkinsonism;
PLA2G6 gene;
Neurodegeneration with brain iron accumulation;
Deep brain stimulation
- From:
Chinese Journal of Neurology
2023;56(12):1389-1397
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To elucidate the clinical and genetic characteristics of PLA2G6-related parkinsonism. Methods:The clinical, imaging and genetic data of 6 patients with PLA2G6-related parkinsonism admitted to Peking Union Medical College Hospital from January 2015 to December 2022 were retrospectively collected and analyzed. The prognosis was followed up through phone call. Results:There were 3 male and 3 female patients, and the age of disease onset was (24.3±5.4) years. Phenotypically, 5 of them had dystonia-parkinsonism (DP) with obvious atrophy of cerebellum and 1 presented as early-onset Parkinson′s disease (EOPD) with no brain structural abnormality. Only 1 patient presented with abnormal brain iron deposition. All of the patients were partially responsive to levodopa. Three cases underwent levodopa challenge test with the objective levodopa responsiveness varied from 10.3% and 10.6% in 2 DP patients, to 77.0% in 1 EOPD patient. Levodopa-induced dyskinesias were present in 4 of them, and all appeared within the first year since the initiation of dopaminergic treatment. Two patients underwent bilateral deep brain stimulation (DBS) of subthalamic nucleus and globus pallidus internus respectively, albeit revealed poor outcome. Genetically, 8 PLA2G6 variants were identified. Two of them were found to be novel (c.1973A>G and exon2 heterozygous deletion), and the most frequent variant was the c.991G>T mutation which was detected in 4 patients. Conclusions:The phenotype of PLA2G6-related parkinsonism is complex. Cerebellar atrophy is a frequent magnetic resonance imaging feature. Levodopa responsiveness tends to depend on the clinical phenotype, and EOPD is better than DP. DBS might not be promising in DP patients with obvious cerebral atrophy. The c.991G>T mutation is the most frequent mutation, suggesting a common founder effect.
